Literature DB >> 140269

[About degradation products of the inter-alpha-trypsin inhibitor in serum. I. The inter-alpha-trypsin inhibitor as precursor of the acid stable trypsin-plasmin-inhibitor of the serum (author's transl)].

K Hochstrasser, J Niebel, H Feuth, K Lempart.   

Abstract

The humoral inter-alpha-trypsin inhibitor is to define as precursor of the acid stable trypsin-plasmin-inhibitor in the serum. The inhibitor is filtrated by the glomerulum and excreted in the urine. The serum level of the inhibitor is increased in nephropathy. Using a new assay for the intact precursor it was found that during inflammation the decreased precursor level indicates an increased turnover, though the glomerular filtration of the acid-stable inhibitor is within normal range. The increase of the precursor level during nephropathy indicates that the kidney is the main degradation organe for the inter-alpha-trypsin inhibitor. Nevertheless, an increase of the acid-stable inhibitor is to be seen. This fact is only to explain if it is assumed that the inter-alpha-trypsin inhibitor is permanently degraded everywhere in the organism.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 140269     DOI: 10.1007/bf01488112

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  10 in total

1.  Liberation of an acid stable proteinase inhibitor from the human inter-alpha-trypsin inhibitor by the action of kallikrein.

Authors:  G Bretzel; K Hochstrasser
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1976-03

2.  Identification of the acid-stable trypsin-plasma inhibitors of the human and bovine serum as Kunitz-type inhibitors. Preliminary sequencing data.

Authors:  K Hochstrasser; E Wachter; G Bretzel
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1976-11

3.  THE BASIC TRYPSIN INHIBITOR OF BOVINE PANCREAS. IV. THE LINEAR SEQUENCE OF THE 58 AMINO ACIDS.

Authors:  B KASSELL; M RADICEVIC; M J ANSFIELD; M LASKOWSKI
Journal:  Biochem Biophys Res Commun       Date:  1965-01-18       Impact factor: 3.575

4.  A proteolytic inhibitor with anticoagulant activity separated from human urine and plasma.

Authors:  N R SHULMAN
Journal:  J Biol Chem       Date:  1955-04       Impact factor: 5.157

5.  The plasminogen activator in urine and the urinary trypsin inhibitor.

Authors:  T ASTRUP; I STERNDORFF
Journal:  Scand J Clin Lab Invest       Date:  1955       Impact factor: 1.713

6.  [The inter-alpha-trypsin inhibitor as precursor of the acid-stable proteinase inhibitors in human serum and urine].

Authors:  K Hochstrasser; G Bretzel; H Feuth; W Hilla; K Lempart
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1976-02

7.  [Characterization of the acid-stable protease inhibitors in human plasma (author's transl)].

Authors:  K Hochstrasser; H Feuth; O Steiner
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1973-08

8.  [Behaviour of acid-stable proteinase inhibitors in serum and urine after kidney transplantations (author's transl)].

Authors:  K Hochstrsser; H Feuth; B Kemkes; J Fall; E Werle
Journal:  Klin Wochenschr       Date:  1974-11-01

9.  [Acidstable proteinaseinhibitors in blood plasma in different nepropathies (author's transl)].

Authors:  K Hochstrasser; H Feuth; J Fall; B Kemkes
Journal:  Klin Wochenschr       Date:  1974-11-01

10.  ISOLATION FROM BEEF PANCREAS OF CRYSTALLINE TRYPSINOGEN, TRYPSIN, A TRYPSIN INHIBITOR, AND AN INHIBITOR-TRYPSIN COMPOUND.

Authors:  M Kunitz; J H Northrop
Journal:  J Gen Physiol       Date:  1936-07-20       Impact factor: 4.086

  10 in total
  3 in total

1.  [Clinical-functional emphysema diagnostics and immunological correlations (author's transl)].

Authors:  J Kowalski; B Rasche; A A Bulgalho de Almeida; K Hochstrasser; W T Ulmer
Journal:  Klin Wochenschr       Date:  1979-05-16

2.  Acid-stable protease inhibitor in chronic phase of carrageenin-induced inflammation in rats.

Authors:  M Sugiki; M Maruyama; E Yoshida; H Sumi; H Mihara
Journal:  Inflammation       Date:  1991-08       Impact factor: 4.092

3.  Disturbances of selected plasma proteins in hyperdynamic septic shock.

Authors:  J Witte; M Jochum; R Scherer; W Schramm; K Hochstrasser; H Fritz
Journal:  Intensive Care Med       Date:  1982       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.